Piperazine substituted benzothiophene compound.
PK140880AUndetermined Publication Date: 2010-09-20OTSUKA PHARM CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200600319
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-09-20
Abstract
The present invention provides a heterocyclic compound represented by the general formula (1) represents -NH-CH2-, -N=CH-, -CH2-NHor -CH=N-); the ring Q may have at least one substituent selected from the group consisting of a lower alkyl group, a lower alkenyl group, R2 represents a hydrogen atom or a lower alkyl group; and A represents -O-A1- (wherein Al represents an alkylene group which may be substituted with a hydroxy group (wherein the alkylene group may contain one oxygen atom) or a lower alkenylene group) or a lower alkylene group)The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders.
Need to check novelty before this filing date? Find Prior Art